Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV Type 1-Infected Patients Using a Nonnucleoside Reverse Transcriptase Inhibitor-Based or a Boosted Protease Inhibitor-Based Antiretroviral Regimen: Three-Year Results (The Advanz Trial): A Randomized, Controlled Trial

José M. Miró; Christian Manzardo; Judith Pich; Pere Domingo; Elena Ferrer; José R. Arribas; Esteban Ribera; Julio Arrizabalaga; Montserrat Loncá; Anna Cruceta; Elisa de Lazzari; Montserrat Fuster; Daniel Podzamczer; Montserrat Plana; José M. Gatell

doi:10.1089/aid.2009.0105

Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV Type 1-Infected Patients Using a Nonnucleoside Reverse Transcriptase Inhibitor-Based or a Boosted Protease Inhibitor-Based Antiretroviral Regimen: Three-Year Results (The Advanz Trial): A Randomized, Controlled Trial

AIDS Research and Human Retroviruses ◽

10.1089/aid.2009.0105 ◽

2010 ◽

Vol 26 (7) ◽

pp. 747-757 ◽

Cited By ~ 12

Author(s):

José M. Miró ◽

Christian Manzardo ◽

Judith Pich ◽

Pere Domingo ◽

Elena Ferrer ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Protease Inhibitor ◽

Immune Reconstitution ◽

Controlled Trial ◽

Transcriptase Inhibitor ◽

Randomized Controlled ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Hiv Type 1 ◽

Reverse Transcriptase Inhibitor

Download Full-text

Efavirenz Is a Potent Nonnucleoside Reverse Transcriptase Inhibitor of HIV Type 1 Replication in Microgliain Vitro

AIDS Research and Human Retroviruses ◽

10.1089/088922200750006056 ◽

2000 ◽

Vol 16 (15) ◽

pp. 1527-1537 ◽

Cited By ~ 9

Author(s):

Andrew V. Albright ◽

Susan Erickson-Viitanen ◽

Michael O'Connor ◽

Ian Frank ◽

Marlene M. Rayner ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Hiv Type 1 ◽

Reverse Transcriptase Inhibitor

Download Full-text

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

AIDS Research and Human Retroviruses ◽

10.1089/088922200414956 ◽

2000 ◽

Vol 16 (12) ◽

pp. 1113-1121 ◽

Cited By ~ 55

Author(s):

Andrew Wiznia ◽

Kenneth Stanley ◽

Paul Krogstad ◽

George Johnson ◽

Sophia Lee ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Controlled Trial ◽

Transcriptase Inhibitor ◽

Nucleoside Analog ◽

Randomized Controlled ◽

Reverse Transcriptase Inhibitor

Download Full-text

Attenuated Infectivity of HIV Type 1 from Epithelial Cells Pretreated with a Tight-Binding Nonnucleoside Reverse Transcriptase Inhibitor

AIDS Research and Human Retroviruses ◽

10.1089/088922202760072339 ◽

2002 ◽

Vol 18 (10) ◽

pp. 711-714 ◽

Cited By ~ 19

Author(s):

Gadi Borkow ◽

Horacio Salomon ◽

Mark A. Wainberg ◽

Michael A. Parniak

Keyword(s):

Epithelial Cells ◽

Reverse Transcriptase ◽

Tight Binding ◽

Transcriptase Inhibitor ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Hiv Type 1 ◽

Reverse Transcriptase Inhibitor

Download Full-text

Substitution of a Nonnucleoside Reverse Transcriptase Inhibitor for a Protease Inhibitor in the Treatment of Patients with Undetectable Plasma Human Immunodeficiency Virus Type 1 RNA

Clinical Infectious Diseases ◽

10.1086/317424 ◽

2000 ◽

Vol 31 (5) ◽

pp. 1274-1278 ◽

Cited By ~ 32

Author(s):

F. Raffi ◽

B. Bonnet ◽

V. Ferre ◽

J.-L. Esnault ◽

P. Perre ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Human Immunodeficiency Virus Type ◽

Transcriptase Inhibitor ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Undetectable Plasma ◽

Immunodeficiency Virus ◽

Reverse Transcriptase Inhibitor

Download Full-text

Short Communication: A Novel Mutation (F227L) Arises in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 on Dose-Escalating Treatment of HIV Type 1-Infected Cell Cultures with the Nonnucleoside Reverse Transcriptase Inhibitor Thiocarboxanilide UC-781

AIDS Research and Human Retroviruses ◽

10.1089/aid.1998.14.255 ◽

1998 ◽

Vol 14 (3) ◽

pp. 255-260 ◽

Cited By ~ 24

Author(s):

JAN BALZARINI ◽

HEIDI PELEMANS ◽

ROBERT ESNOUF ◽

ERIK DE CLERCQ

Keyword(s):

Reverse Transcriptase ◽

Short Communication ◽

Novel Mutation ◽

Transcriptase Inhibitor ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Immunodeficiency Virus ◽

Hiv Type 1 ◽

Reverse Transcriptase Inhibitor ◽

Dose Escalating

Download Full-text

Efficacy, Pharmacokinetics, andin VivoAntiviral Activity of UC781, a Highly Potent, Orally Bioavailable Nonnucleoside Reverse Transcriptase Inhibitor of HIV Type 1

AIDS Research and Human Retroviruses ◽

10.1089/aid.1997.13.789 ◽

1997 ◽

Vol 13 (9) ◽

pp. 789-796 ◽

Cited By ~ 23

Author(s):

ROBERT W. BUCKHEIT ◽

MELINDA HOLLINGSHEAD ◽

SHERMAN STINSON ◽

VALERIE FLIAKAS-BOLTZ ◽

LUKE A. PALLANSCH ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Hiv Type 1 ◽

Orally Bioavailable ◽

Reverse Transcriptase Inhibitor

Download Full-text

Initial highly-active antiretroviral therapy with a protease inhibitor versus a nonnucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect metaanalyses

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70040-3 ◽

2007 ◽

Vol 2007 ◽

pp. 61-62

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Highly Active Antiretroviral Therapy ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Download Full-text

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing nonnucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: openlabel randomised trial

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70039-7 ◽

2007 ◽

Vol 2007 ◽

pp. 60-61

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Randomised Trial ◽

Transcriptase Inhibitor ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Download Full-text

351-OR: Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes: Cost-Effectiveness Analyses of the CONCEPTT Randomized Controlled Trial

Diabetes ◽

10.2337/db19-351-or ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 351-OR

Author(s):

HELEN R. MURPHY ◽

DENICE FEIG ◽

NASHITA PATEL

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Pregnant Women ◽

Continuous Glucose Monitoring ◽

Controlled Trial ◽

Glucose Monitoring ◽

Randomized Controlled

Download Full-text

Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results

10.26226/morressier.5aeaf2d35800a00019097f88 ◽

2018 ◽

Author(s):

Jürgen K. Rockstroh ◽

Christian Wisskirchen

Keyword(s):

Randomized Controlled Trial ◽

Protease Inhibitor ◽

Controlled Trial ◽

Fixed Dose ◽

Phase 3 ◽

Randomized Controlled ◽

Tenofovir Alafenamide

Download Full-text